Development and Validation of the Blood Glucose Measurement Device by Air Analysis Expired
A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 130 participants.
Also called NCT05207020
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose diagnostic
- Phase
- Not applicable
- Enrolled
- 130 participants
- Registry
-
NCT05207020
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- France
- Registry status
- Completed
Technical summary
Registry record NCT05207020. Allocation not applicable; no masking; primary purpose diagnostic. Start 2021-12-01 (actual); primary completion 2023-02-09 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Development and Validation of the Blood Glucose Measurement Device by Air Analysis Expired
- Acronym
- BOYDSENSE
- Condition
- Diabetes Mellitus, Type 2
- Intervention (Device)
- Glycemia estimated by exhaled air analyzer
- Intervention (Behavioral)
- Questionnaire
- Intervention (Biological)
- Veinous glycemia
- Intervention (Biological)
- Capillary glycemia
- Intervention (Biological)
- constitution biological collection
- Intervention (Biological)
- Blood sample
- Intervention (Other)
- Test meal
- Lead sponsor
- University Hospital, Toulouse
Record details
- Record id
cardio:ct-nct05207020- Content hash
a5b26582db1e920ea658ea53ec314262c9a76973778057a220b5a6e8494ae522